Isthmus Partners’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-176,170
| Closed | -$264K | – | 273 |
|
|
2018
Q1 | $264K | Buy |
176,170
+11,595
| +7% | +$17.4K | 0.07% | 120 |
|
|
2017
Q4 | $234K | Buy |
164,575
+4,084
| +3% | +$5.81K | 0.06% | 123 |
|
|
2017
Q3 | $368K | Buy |
160,491
+6,104
| +4% | +$14K | 0.1% | 114 |
|
|
2017
Q2 | $208K | Buy |
154,387
+1,285
| +0.8% | +$1.73K | 0.06% | 126 |
|
|
2017
Q1 | $328K | Buy |
153,102
+7,110
| +5% | +$15.2K | 0.1% | 118 |
|
|
2016
Q4 | $644K | Buy |
145,992
+8,443
| +6% | +$37.2K | 0.19% | 95 |
|
|
2016
Q3 | $681K | Buy |
137,549
+28,054
| +26% | +$139K | 0.22% | 80 |
|
|
2016
Q2 | $361K | Buy |
109,495
+62,053
| +131% | +$205K | 0.12% | 110 |
|
|
2016
Q1 | $168K | Buy |
+47,442
| New | +$168K | 0.06% | 130 |
|